Xiao-Feng Li, Qiang Fu, You-Wen Dong, Jian-Jing Liu, Xiu-Yu Song, Dong Dai, Cong Zuo, Wen-Gui Xu
Xiao-Feng Li, Qiang Fu, You-Wen Dong, Jian-Jing Liu, Xiu-Yu Song, Dong Dai, Cong Zuo, Wen-Gui Xu, Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
Xiao-Feng Li, Qiang Fu, You-Wen Dong, Jian-Jing Liu, Xiu-Yu Song, Dong Dai, Cong Zuo, Wen-Gui Xu, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Author contributions: Li XF designed the study, analyzed the data and wrote the paper; Fu Q, Dong YW and Zuo C collected the data; Liu JJ, Song XY and Dai D performed the data analysis; Xu WG designed the study, and revised the paper; all authors have read and approved the final version to be published.
Supported by the National Natural Science Foundation of China, No. 81501984 and No. 81601377; Tianjin Municipal Bureau of Health Science and Technology, No. 2015KZ084 and No. 2013KZ088; and Tianjin Medical University Science, No. 2013KYQ07.
Institutional review board statement: The study was reviewed and approved by the Tianjin Medical University Cancer Institute and Hospital Institutional Review Board.
Informed consent statement: Due to the retrospective nature of the study, patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to receive examination of 18F-fluorodeoxyglucose positron emission tomography/computed tomography by written informed consent.
Conflict-of-interest statement: The authors declare no conflict of interest related to this study.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Wen-Gui Xu, MD, Professor, Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Huan-Hu-Xi Road, Ti-Yuan-Bei, Hexi District, Tianjin 300060, China.
wxu06@tmu.edu.cn
Telephone: +86-22-23340123-5923 Fax: +86-22-23537796
Received: April 19, 2016
Peer-review started: April 21, 2016
First decision: May 12, 2016
Revised: May 20, 2016
Accepted: June 15, 2016
Article in press: June 15, 2016
Published online: September 14, 2016
Processing time: 142 Days and 0.2 Hours
